Developed by researchers at the University of Wisconsin-Madison, the method is an improved version of electron transfer dissociation that fragments peptides more thoroughly.
Presented this week at the ECCMID annual meeting, the method uses mass spec to detect alterations to bacteria lipopolysaccharides that confer resistance.
Gyros will distribute certain of Luxembourg Bio Technologies' coupling agents for peptide synthesis.
Driven by strong demand from the company's pharma customers, it posted sales of $498 million, beating the average Wall Street estimate of $488.6 million.
The deal gives Tanon rights to sell Sygnis's InstantBlue stain and Ultrafast blotting buffer in China and expands on a previous deal covering precast gels.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.